Therapeutic effects and potential mechanisms of astragaloside IV on pulmonary fibrosis: a systematic review and meta-analysis of preclinical studies
BackgroundPulmonary fibrosis (PF) remains a devastating disease with limited therapeutic options. Astragaloside IV (AS-IV), a natural compound from Astragalus mongholicus (AM), has shown promise as a possible treatment for fibrosis. However, a systematic evaluation of its therapeutic efficacy and un...
Saved in:
| Main Authors: | Shujuan Zhang, Yan Xue, Xing Zhang, Feng Chen, Yalan Li, Wei Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1564290/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploratory review on the effect of Astragalus mongholicus on signaling pathways
by: Inmaculada Xu Lou, et al.
Published: (2024-12-01) -
Therapeutic potential and mechanistic insights of astragaloside IV in the treatment of arrhythmia: a comprehensive review
by: Meilian Chen, et al.
Published: (2025-04-01) -
Astragaloside IV: a potential nemesis for gastric cancer
by: Chao Hu, et al.
Published: (2025-07-01) -
Astragaloside IV increases PDHA1 in mesenchymal stem cell exosomes to treat myocardial infarction
by: Sha Zhongxin, et al.
Published: (2025-07-01) -
Astragaloside IV represses hepatocellular carcinoma progression by modulating HMGB1-ferroptosis axis
by: Xingyang Zhao, et al.
Published: (2025-08-01)